Orchid Pharma Limited announced that Mr. Mridul Dhanuka, Whole Time Director, will be participating in an investor roadshow in Mumbai. The event is scheduled to take place from September 28 to September 30, 2026. This roadshow is part of the company’s efforts to engage with investors and is expected to provide insights into its business and future plans. No Unpublished Price Sensitive Information (UPSI) will be shared during these meetings.
Investor Roadshow Announced
Orchid Pharma Limited has officially announced its participation in an investor roadshow to be held in Mumbai. The event will see Mr. Mridul Dhanuka, the company’s Whole Time Director, engage with potential investors and stakeholders. This initiative underscores the company’s commitment to transparency and investor relations. The roadshow aims to provide a platform for dialogue and to convey the company’s strategic direction and operational updates.
Schedule and Location
The investor roadshow is scheduled to commence on Monday, September 28, 2026, and will continue until Wednesday, September 30, 2026. The meetings will be conducted in Mumbai, with specific modes of interaction including group meets and physical engagements. The detailed schedule is as follows:
- Monday, September 28, 2026: Group Meet, Physical, Mumbai
- Tuesday, September 29, 2026
- Wednesday, September 30, 2026
It is important to note that the schedule is subject to unforeseen changes. Any updates or alterations will be communicated promptly to relevant parties. Orchid Pharma emphasizes that during these meetings, no Unpublished Price Sensitive Information (UPSI) will be disclosed, ensuring fair and equitable dissemination of information.
Source: BSE
